ADAMTS9‐AS2 like ADAMTS9 is downregulated in glioblastoma (Yao et al., 2014), colorectal cancer (Li et al., 2016), bladder cancer, lung adenocarcinoma, and ER+ breast cancers (Li et al., 2017). Here, ADAMTS9 is linked to urinary bladder cancer.